ADVERTISEMENT

Ghana eliminates trachoma, freeing millions from suffering and blindness

Ghana is the first country in WHO’s African Region to achieve this milestone.

The announcement comes the day after a commitment from Pfizer, the manufacturer of Zithromax (azithromycin), to extend their donation programme for the antibiotic until 2025, if required, to finish the task of global trachoma elimination.

“It’s been 20 years since the global health community committed to eliminating trachoma worldwide,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “Although there’s more work to do elsewhere, the validation of elimination in Ghana allows another previously heavily-endemic country to celebrate significant success.”

According to the country’s health minister Kwaku Agyemang-Manu, the success is a result of a tremendous amount of hard work by thousands of health, education and development workers to improve the lives of individuals with trachoma and their families.

ADVERTISEMENT

The global trachoma community learnt a lot from Ghana’s experience.

Innovations used included height-based dosing for azithromycin; systematic active case-searches for trichiasis involving door-to-door, community-by-community fieldwork; and, intensive counselling of patients found to have trichiasis with an offer of immediate surgery, which produced considerable improvement in surgical uptake.

Matshidiso Moeti, WHO Regional Director for Africa believes that Ghana’s success is due to the strong leadership at all levels

Trachoma: Ghana’s story Trachoma was identified in the 1950s as the most important cause of blindness in Ghana.

By the 1990s, the disease was known to persist as a significant public health problem in the Northern and Upper West Regions.

ADVERTISEMENT

There were about 2.8 million people at risk of trachomatous blindness nationally, with an estimated 13 000 people suffering from trichiasis.

In 2000, the Ministry of Health and Ghana Health Service set up a national Trachoma Elimination Programme.

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.com.gh

ADVERTISEMENT